ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Boston-based synthetic biology company Ginkgo Bioworks has launched a biosecurity initiative to help predict biological warfare and infectious disease threats. For Ginkgo, the initiative incorporates existing contracts totaling up to $64 million from the U.S. Intelligence Advanced Research Projects Activity (IARPA), the Department of Defense, and the Department of Homeland Security. For one IARPA-sponsored project, Ginkgo will develop algorithms along with Battelle, One Codex, and Twist Bioscience to detect potential threats from known and unknown DNA sequences.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter